У нас вы можете посмотреть бесплатно OutSmarting Osteosarcoma 2025 Award Presentation to David Ulmert, MD - Because of Sydney или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
OutSmarting Osteosarcoma 2025 Hero Awards Moderators: Christina Ip-Toma | MIB Agents Matteo Trucco, MD | Cleveland Clinic Amy LeBlanc, DVM | National Cancer Institute A comparative approach to exploring fluorescence in situ hybridisation (FISH) biomarkers for advancing the diagnosis, prognostication and treatment of osteosarcoma Corey Weistuch, PhD | Memorial Sloan Kettering Cancer Center Implementing personalized, adaptive therapies in osteosarcoma Alexander Davies, DVM, PhD | Oregon Health and Science University Validation of MCL1 inhibition and combinatorial therapy for elimination of osteosarcoma lung metastasis David Ulmert, MD, PhD | University of California, Los Angeles Because of Sydney High-throughput characterization of pathobiological responses in osteosarcoma tumors treated with LRRC15-targeted radiotherapy to uncover curative co-treatment approaches Ram Rao, MD, PhD | Seattle Children's Hospital Extracellular matrix degradation to overcome osteosarcoma chemoresistance Aafrin M. Pettiwala, PhD | University of California, San Francisco Identifying mechanisms of chemoresistance in metastatic osteosarcoma using molecular barcoding Ali Cihan, PhD | Memorial Sloan Kettering Cancer Center Because of Isaac Targeting EPHA2 with dual-armored CAR T cells for immunotherapy in pediatric osteosarcoma Janeala Morsby, PhD | St. Jude Children's Research Hospital Because of Buddy Synergy of ATM and PARP inhibitors in pediatric osteosarcoma Joseph Skeate, PhD | University of Minnesota Because of Annaleigh Next generation dual-CAR gamma delta T cells for the treatment of pediatric osteosarcoma Andrew S. Clugston, PhD | University of California, San Francisco In partnership with the RISE Foundation, Because of Reese Oncogenic structural variation in the genome of pediatric osteosarcoma ---- Want to support our mission? Donate here: https://give-usa.keela.co/embed/YAipu... Factor 2025 Registration - https://www.mibagents.org/research/fa... Bing Osteosarcoma Auction - https://tockify.com/mibagents/detail/... Instagram - / mib.agents X - https://x.com/AgentsMIB Facebook - / mibagents Stay updated with the latest news and events: https://www.mibagents.org/how-to-help...